{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:00:29Z","timestamp":1790780429794,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"DOI":"10.1007\/s00406-026-02393-w","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:38:26Z","timestamp":1790779106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The discontinuation-emergent signs and symptoms (DESS) scale: reliable measurement\u2014but perhaps not of antidepressant withdrawal"],"prefix":"10.1007","author":[{"given":"Reinhard","family":"Ma\u00df","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2393_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.addbeh.2018.08.027","volume":"97","author":"J Davies","year":"2019","unstructured":"Davies J, Read J (2019) A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based? Addict Behav 97:111\u2013121. https:\/\/doi.org\/10.1016\/j.addbeh.2018.08.027","journal-title":"Addict Behav"},{"key":"2393_CR2","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1177\/106002809302700912","volume":"27","author":"EM Garner","year":"1993","unstructured":"Garner EM, Kelly MW, Thompson DF (1993) Tricyclic antidepressant withdrawal syndrome. Ann Pharmacother 27:1068\u20131072. https:\/\/doi.org\/10.1177\/106002809302700912","journal-title":"Ann Pharmacother"},{"key":"2393_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000491524","volume":"87","author":"GA Fava","year":"2018","unstructured":"Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J (2018) Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review. Psychother Psychosom 87:195\u2013203. https:\/\/doi.org\/10.1159\/000491524","journal-title":"Psychother Psychosom"},{"key":"2393_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000370338","volume":"84","author":"GA Fava","year":"2015","unstructured":"Fava GA, Gatti A, Belaise C, Guidi J, Offidani E (2015) Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom 84:72\u201381. https:\/\/doi.org\/10.1159\/000370338","journal-title":"Psychother Psychosom"},{"key":"2393_CR5","doi-asserted-by":"publisher","first-page":"204512532092169","DOI":"10.1177\/2045125320921694","volume":"10","author":"MP Hengartner","year":"2020","unstructured":"Hengartner MP (2020) How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding. Ther Adv Psychopharmacol 10:2045125320921694. https:\/\/doi.org\/10.1177\/2045125320921694","journal-title":"Ther Adv Psychopharmacol"},{"key":"2393_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1192\/bja.2021.62","volume":"28","author":"MA Horowitz","year":"2022","unstructured":"Horowitz MA, Taylor D (2022) Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies. BJPsych Adv 28:297\u2013311. https:\/\/doi.org\/10.1192\/bja.2021.62","journal-title":"BJPsych Adv"},{"key":"2393_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0006-3223(98)00126-7","volume":"44","author":"JF Rosenbaum","year":"1998","unstructured":"Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB (1998) Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 44:77\u201387. https:\/\/doi.org\/10.1016\/s0006-3223(98)00126-7","journal-title":"Biol Psychiatry"},{"key":"2393_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/JCP.0000000000001491","volume":"42","author":"F Cosci","year":"2022","unstructured":"Cosci F, Romanazzo S, Mansueto G, Rontani P, Levitan MN, Halkj\u0153r-Lassen RD et al (2022) Clinical utility of semistructured interview and scales to assess withdrawal syndromes with dose reduction or discontinuation of selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors. J Clin Psychopharmacol 42:17\u201322. https:\/\/doi.org\/10.1097\/JCP.0000000000001491","journal-title":"J Clin Psychopharmacol"},{"key":"2393_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jad.2018.10.107","volume":"245","author":"E Maund","year":"2019","unstructured":"Maund E, Dewar-Haggart R, Williams S, Bowers H, Geraghty AWA, Leydon G et al (2019) Barriers and facilitators to discontinuing antidepressant use: a systematic review and thematic synthesis. J Affect Disord 245:38\u201362. https:\/\/doi.org\/10.1016\/j.jad.2018.10.107","journal-title":"J Affect Disord"},{"key":"2393_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12888-023-04941-3","volume":"23","author":"C Mei\u00dfner","year":"2023","unstructured":"Mei\u00dfner C, Warren C, Fadai T, M\u00fcller A, Zapf A, Lezius S et al (2023) Disentangling pharmacological and expectation effects in antidepressant discontinuation among patients with fully remitted major depressive disorder: study protocol of a randomized, open-hidden discontinuation trial. BMC Psychiatry 23:457. https:\/\/doi.org\/10.1186\/s12888-023-04941-3","journal-title":"BMC Psychiatry"},{"key":"2393_CR11","volume-title":"IDCL: Internationale Diagnosen-Checklisten f\u00fcr ICD-10 und DSM-IV","author":"W Hiller","year":"1995","unstructured":"Hiller W, Zaudig M, Mombour W (1995) IDCL: Internationale Diagnosen-Checklisten f\u00fcr ICD-10 und DSM-IV. Huber, Bern"},{"key":"2393_CR12","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s00213-023-06417-4","volume":"240","author":"R Ma\u00df","year":"2023","unstructured":"Ma\u00df R, Backhaus K, Lohrer K, Szelies M, Unkelbach BK (2023a) No benefit of antidepressants in inpatient treatment of depression. A longitudinal, quasi-experimental field study. Psychopharmacology 240:1963\u20131971. https:\/\/doi.org\/10.1007\/s00213-023-06417-4","journal-title":"Psychopharmacology"},{"key":"2393_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/wps.21069","volume":"22","author":"P Cuijpers","year":"2023","unstructured":"Cuijpers P, Miguel C, Harrer M, Plessen CY, Ciharova M, Ebert D, Karyotaki E (2023) Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta-analysis including 409 trials with 52,702 patients. World Psychiatry 22:105\u2013115. https:\/\/doi.org\/10.1002\/wps.21069","journal-title":"World Psychiatry"},{"key":"2393_CR14","doi-asserted-by":"publisher","first-page":"1415905","DOI":"10.3389\/fpsyt.2024.1415905","volume":"15","author":"U Voderholzer","year":"2024","unstructured":"Voderholzer U, Barton BB, Favreau M, Zisler EM, Rief W, Wilhelm M, Schramm E (2024) Enduring effects of psychotherapy, antidepressants and their combination for depression: a systematic review and meta-analysis. Front Psychiatry 15:1415905. https:\/\/doi.org\/10.3389\/fpsyt.2024.1415905","journal-title":"Front Psychiatry"},{"key":"2393_CR15","volume-title":"Beck Depression Inventory \u2013 second edition (3rd revised edition; German adaptation by Hautzinger M, Keller F, K\u00fchner C)","author":"AT Beck","year":"2023","unstructured":"Beck AT, Steer RA, Brown GK (2023) Beck Depression Inventory \u2013 second edition (3rd revised edition; German adaptation by Hautzinger M, Keller F, K\u00fchner C). Pearson Clinical and Talent Assessment, Frankfurt\/Main"},{"key":"2393_CR16","doi-asserted-by":"publisher","unstructured":"Kalfas M, Tsapekos D, Butler M, McCutcheon RA, Pillinger T, Strawbridge R et al (2025) Incidence and nature of antidepressant discontinuation symptoms: a systematic review and meta-analysis. JAMA Psychiatry 82. https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.1362","DOI":"10.1001\/jamapsychiatry.2025.1362"},{"key":"2393_CR17","volume-title":"Using multivariate statistics","author":"BG Tabachnick","year":"2019","unstructured":"Tabachnick BG, Fidell LS (2019) Using multivariate statistics, 7th edn. Pearson, New York, NY","edition":"7"},{"key":"2393_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4068\/cmj.2018.54.2.101","volume":"54","author":"SM Wang","year":"2018","unstructured":"Wang SM, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS, Pae CU (2018) Addressing the side effects of contemporary antidepressant drugs: a comprehensive review. Chonnam Med J 54:101\u2013112. https:\/\/doi.org\/10.4068\/cmj.2018.54.2.101","journal-title":"Chonnam Med J"},{"key":"2393_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","volume":"334","author":"O Lingjaerde","year":"1987","unstructured":"Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987) The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 334:1\u2013100. https:\/\/doi.org\/10.1111\/j.1600-0447.1987.tb10566.x","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"2393_CR20","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00406-025-02005-z","volume":"276","author":"C Volkmann","year":"2026","unstructured":"Volkmann C, Abulikemu S, Berwian IM, Quentin JMH, Walter H (2026) Do withdrawal symptoms predict depression relapse after antidepressant cessation? Eur Arch Psychiatry Clin Neurosci 276:749\u2013760. https:\/\/doi.org\/10.1007\/s00406-025-02005-z","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2393_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000528902","volume":"33","author":"R Ma\u00df","year":"2023","unstructured":"Ma\u00df R, Backhaus K, Szelies M, Unkelbach BK (2023b) Effektivit\u00e4t von Antidepressiva bei der vollstation\u00e4ren Psychotherapie von Depression: eine naturalistische kontrollierte Studie. Verhaltenstherapie 33:15\u201325. https:\/\/doi.org\/10.1159\/000528902","journal-title":"Verhaltenstherapie"},{"key":"2393_CR22","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1017\/S2045796019000520","volume":"29","author":"J Moncrieff","year":"2020","unstructured":"Moncrieff J (2020) Persistent adverse effects of antidepressants. Epidemiol Psychiatr Sci 29:e56. https:\/\/doi.org\/10.1017\/S2045796019000520","journal-title":"Epidemiol Psychiatr Sci"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-026-02393-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-026-02393-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-026-02393-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:38:28Z","timestamp":1790779108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-026-02393-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":22,"alternative-id":["2393"],"URL":"https:\/\/doi.org\/10.1007\/s00406-026-02393-w","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the German Society for Psychology (Deutsche Gesellschaft f\u00fcr Psychologie) under reference number Ma\u00dfReinhard2023-04-29AM. All patients were informed about the aims of the study and provided written informed consent to participate.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}